Lyle A. Hohnke

Lyle A. Hohnke

Plus aucun poste en cours
82 ans
Health Technology
Consumer Services
Commercial Services

Profil

Dr. Lyle A. Hohnke is Independent Director at Nuo Therapeutics, Inc. He is on the Board of Directors at Nuo Therapeutics, Inc. and BioRexis Pharmaceutical Corp.
Dr. Hohnke was previously employed as Chief Executive Officer & Director by Aldagen, Inc., a Principal by Tullis-Dickerson & Co., Inc., Chairman by Vaxin, Inc., Chairman & Chief Executive Officer by Diamond Animal Health, Inc., Co-Founder by Targetech, Inc., President by The University of Connecticut Research & Development Corp., a Principal by Pfizer Central Research, and VP-Research, Director-Patents & License by University of Connecticut Health Center.
He also served on the board at Synageva BioPharma Corp., Heska Corp., TransMolecular, Inc., and Valeo Medical, Inc. He received his undergraduate degree from Western Michigan University, a graduate degree from the University of Oregon, an MBA from Rensselaer Polytechnic Institute, and a doctorate degree from the University of Oregon.

Anciens postes connus de Lyle A. Hohnke

SociétésPosteFin
NUO THERAPEUTICS, INC. Directeur/Membre du Conseil 13/08/2015
President 01/02/2012
Directeur/Membre du Conseil 27/06/2011
Directeur/Membre du Conseil 03/11/2009
Private Equity Investor 31/12/2008
Voir l'expérience en détail de Lyle A. Hohnke

Formation de Lyle A. Hohnke

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

29

Relations au 1er degré

17

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées17

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Commercial Services

Consumer Services

Consumer Services

Consumer Services

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Services

Commercial Services

  1. Bourse
  2. Insiders
  3. Lyle A. Hohnke
- 40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT